Skin injuries lead to a large burden of morbidity. Although numerous clinical and scientific strategies have been investigated to repair injured skin, optimal regeneration therapy still poses a considerable obstacle. To address this challenge, the decellularized extracellular matrix-based scaffolds recellularized with stem cells offer significant advancements in skin regeneration and wound healing. Herein, a decellularized human placental sponge (DPS) was fabricated using the decellularization and freeze-drying technique, and then re-cellularized with human adipose-derived mesenchymal cells (MSCs). The biological and biomechanical properties and skin full-thickness wound healing capacity of the stem cells-DPS constructs were investigated in vitro and in vivo. The DPS exhibited a uniform three-dimensional microstructure with an interconnected pore network, 89.21% porosity, a low degradation rate, and good mechanical properties. The DPS and MSCs-DPS constructs were implanted in skin full-thickness wound models in mice. An accelerated wound healing was observed in the wounds implanted with MSCs-DPS construct when compared to DPS and control (wounds with no treatment) during 7 and 21 days post-implantation follow-up. In the MSCs-DPS group, the wound was completely re-epithelialized, the epidermis layer was properly organized, and the dermis and epidermis' bilayer structures were restored after 7 days. Our findings suggest DPS is an excellent carrier for MSCs culture and delivery to skin wounds and now promises to proceed with clinical evaluations.
One of the factors that causes severe metabolic imbalance and abnormal changes in many tissues, especially in the pancreas, is the pathological disease of diabetes mellitus. Therefore, in this study, the therapeutic effects of Scrophularia striata were investigated using an animal model in the control of diabetic injury and pancreatic complications caused by diabetes. A total of 66 rats (weight 220–250 g) were randomly divided into: Healthy Control group (rats without diabetes receiving Propylene glycol as solvent); Diabetic control group; 3 experimental healthy groups (receiving the extract with doses of 100, 200 and 400 mg/kg bw/day); 3 treatment groups; and3 pretreatment groups. Diabetes was induced in rats by intraperitoneal STZ (60 mg/kg bw). FBS, HbA1c and insulin were measured after 4 weeks. Pdx1 and Ins1 gene expression was assessed by RT-PCR. The histological evaluation was also performed with H&E staining. The data were analyzed by SPSS ver20 using ANOVA and Tukey tests. By treatment with S. striata ethanolic extract, these factors were close to the normal range. The expression of the Pdx1 and Ins1 genes increased in the treated rats with S. striata extract. Analysis of the obtained data indicates the effect of S. striata in improving the complications of diabetes in rats and can be considered for therapeutic purposes.
Background: Diabetes mellitus (DM) is a pathological disease that results in severe metabolic imbalances and abnormal changes in many tissues, especially in the pancreas, where oxidative stress plays an important role in etiology. Therefore, the therapeutic effects of Scrophularia striata were investigated using an animal model in the control of diabetic injury and pancreatic complications caused by diabetes. Methods: A total of 66 rats (weight 220-250 g) were randomly divided into: Healthy Control group; Diabetic control group; 3 experimental healthy groups; 3 treatment groups; and3 pretreatment groups. Diabetes was induced in rats by intraperitoneal STZ (60 mg/kg bw). FBS, HbA1c and insulin were measured after four weeks. Pdx1 and Ins1 gene expression was assessed by RT-PCR. The histological evaluation was also performed with H&E staining. The data were analyzed by SPSS ver20 using ANOVA and Tukey tests.Results: By treatment with S. striata ethanolic extract, these factors were close to the normal range. The expression of the Pdx1 and Ins1 genes increased in the treated rats after treatment with S. striata extract. Conclusions: Therefore, by improving serum indexes and Pdx1 and Ins1 gene expression, S. striata may be used as adjuvant therapy for complications of diabetes.
Background: Liver fibrosis is an important health problem in the world; the excessive deposition of type 1 collagen is the most characteristic feature of liver fibrosis. Algae is one of the natural resources that contains biologically active compounds that have anti-inflammatory, antioxidant and immune-stimulating properties. In this study, the effect of brown algae Nizimuddinia zanardinii on liver damage caused by cholestatic liver fibrosis in rats was evaluated. Material and Methods: 54 male rats were randomly classified in nine groups: control, sham, BDL, treatment and Nizimuddinia control. In the treatment group, after BDL, rats were given Nizimuddinia zanradinii extract via intragastric gavage for 45 days (once per day). parameters contains ALT, AST, ALP, cholesterol, triglyceride, albumin, total protein, SOD and CAT and histopathological assessments evaluated. Results: Treatment with Nizimuddinia zanardinii significantly weakened these alterations. In order to, in the treatment groups, TGF-β1 expression was severe, noticeable and low, respectively. In treatment groups, α-SMA expression was remarkable and mildly observed in hepatocytes and hyperplastic bile ducts, respectively. Conclusions: Based on this study, the N. zanardinii extract may protect the liver and have anti-fibrotic effects through its antioxidant and reducing the expression of TGF-β1 and α-SMA.
Background: Liver fibrosis is an important health problem in the world; the excessive deposition of type 1 collagen is the most characteristic feature of liver fibrosis. Algae is one of the natural resources that contains biologically active compounds that have anti-inflammatory, antioxidant and immune-stimulating properties. In this study, the effect of brown algae Nizimuddinia zanardinii on liver damage caused by cholestatic liver fibrosis in rats was evaluated.Material and Methods: 54 male rats were randomly classified in nine groups: control, sham, BDL, treatment and Nizimuddinia control. In the treatment group, after BDL, rats were given Nizimuddinia zanradinii extract via intragastric gavage for 45 days (once per day). parameters contains ALT, AST, ALP, cholesterol, triglyceride, albumin, total protein, SOD and CAT and histopathological assessments evaluated.Results: Treatment with Nizimuddinia zanardinii significantly weakened these alterations. In order to, in the treatment groups, TGF-β1 expression was severe, noticeable and low, respectively. In treatment groups, α-SMA expression was remarkable and mildly observed in hepatocytes and hyperplastic bile ducts, respectively.Conclusions: Based on this study, the N. zanardinii extract may protect the liver and have anti-fibrotic effects through its antioxidant and reducing the expression of TGF-β1 and α-SMA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.